Sobi to Acquire CTI BioPharma | MarketScreener
Transaction Price of $9.10 Per Share Represents Compelling 89% Premium to CTI's Closing Stock Price on May 9, 2023 SEATTLE, May 10, 2023 /PRNewswire/ -- CTI BioPharma , a commercial... | May 10, 2023
Source: marketscreener.com